Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017

Date: January 14, 2013
Pages: 136
Price:
US$ 4,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M776226D7ACEN
Leaflet:

Download PDF Leaflet

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.

Metabolomics Market – Analysis of Global Technology, Application Trends and Landscape 2012-2017 report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as, (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept to drive R&D activity within the industry, (ii) rapid growth of metabolomics data analysis softwares and solutions, and (iii) the advancement of analytical technologies. Metabolomics is used in the identification of new biomarkers, which indicate a change in the physiological state of a cell or tissue. Biomarker screening is important in the process of new drug discovery, and is also a key in vitro diagnostics tool. Additionally it is also being used for environmental toxicology screening. While, there are major concerns of this market such as the validation challenges, the positive aspects may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: Metabolon Inc (U.S.), Metanomics (Germany), Metabolomic Technologies Inc. (U.S.), Human Metabolome Technologies (Japan), Beckman Coulter (U.S.), Agilent Technologies Inc (U.S.), Bruker Corporation (U.S.), Waters Corporation (U.S.), Biocrates Lifesciences (Austria), Chenomx Inc (Canada), Eisai co. ltd (Japan), Nextgen Metabolomics (U.S.), Phenomenome Discoveries Inc. (Canada) and Metabolomic Discoveries (Germany).

Scope of the Report

This technology report categorizes the market for metabolomics by geographical region (including the important countries in each region), applications, and indications, forecasting the market value in revenue by analyzing the trends in detection instruments and separation techniques (E.g. HPLC, Capillary Electrophoresis).

A detailed description of global technological developments and evolving trends in the field of metabolomics with key prominence on product innovations by industries and collaborative efforts by the academic research institutions.

A comprehensive picture of different types of detection instruments available for metabolite analysis (e.g. Mass Spectrometry, NMR, Electrochemical detection and Ion mobility spectrometer), prioritized based on critical criterias through Analytical Hierarchy Process (AHP).

An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of metabolomics market during the forecast period from 2012 to 2017.

Market size - Global market forecast for the next 5 years from 2012 – 2017 by including demand side analysis and strategic recommendations for technology/product developers.

Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.
1. INTRODUCTION

1.1 Key Take-Aways
1.2 Report Scope
1.3 Research Methodology
1.4 Key Data Points From Secondary Sources

2. EXECUTIVE SUMMARY

3. METABOLOMICS –TECHNOLOGY LANDSCAPE ANALYSIS

3.1 Introduction
3.2 Metabolomics and Metabonomics
3.3 Separation Techniques - High Performance Liquid Chromatography (HPLC)
3.4 Separation Techniques – Capillary Electrophoresis (CE)
3.5 Detection Techniques – Mass Spectrometry (MS)
3.6 Detection Techniques – Nuclear Magnetic Resonance (NMR)
3.7 Detection Techniques – Surface Based Mass Analysis
3.8 Key Application Areas
  3.8.1 Biomarker Discovery
  3.8.2 Drug Discovery
  3.8.3 Toxicity Assessment/Toxicology
  3.8.4 Nutri-Genomics
3.9 Conceptual Approach
  3.9.1 Target Analysis
  3.9.2 Metabolite Profiling
  3.9.3 Metabolite Fingerprinting
3.10 Technology Trends in Metabolomics
3.11 Value Chain Analysis

4. METABOLOMICS – MARKET LANDSCAPE ANALYSIS

4.1 Global Metabolomics Market Segmentation
4.2 Market Forecast
  4.2.1 Global Metabolomics Market Revenue Forecast – Introduction
  4.2.2 Global Metabolomics Market Revenue – Regional
  4.2.3 Global Metabolomics Market Revenue – Indication
  4.2.4 Global Metabolomics Market Revenue, By Application
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Challenges
  4.3.4 Emerging Trends
4.4 Demand Side Analysis

5. METABOLOMICS - TECHNOLOGY INVESTMENT POTENTIAL

5.1 Investment Climate Assessment
  5.1.1 Investment Client Networks
    5.1.1.1 Funding Bodies
    5.1.1.2 Insights on Current & Future Tech-investment Trend
  5.1.2 Funding Opportunities
  5.1.3 Analysis of Potential Areas for Technology Investment using Strategic Evaluation

6. METABOLOMICS – GEOGRAPHICAL ANALYSIS

6.1 Introduction
6.2 U.S., Canada, Mexico
6.3 Europe
6.4 Asia & Rest of the World (ROW)

7. COMPETITIVE LANDSCAPE ANALYSIS

7.1 Mergers & Acquisitions
7.2 New Product Developments
7.3 Collaborations

8. PATENT ANALYSIS

8.1 Patent Analysis

9. TECHNOLOGY ANALYSIS (USING MULTI CRITERIA DECISION MAKING) & ROAD MAPPING

9.1 Level 0 Criteria Description
9.2 Comparison of Devices Based on Level 0 Criteria
9.3 Technology Prioritization and AHP Analysis Findings
9.4 Technology Roadmap

10 ANALYST INSIGHTS & RECOMMENDATIONS

10.1 Analyst Insights
10.2 Strategic Recommendations for Technology & Business Management

11 COMPANY PROFILES

11.1 AGILENT TECHNOLOGIES
11.2 BRUKER CORPORATION
11.3 METABOLOMIC TECHNOLOGIES
11.4 METABOLON
11.5 CHENOMX
11.6 BIO-RAD LABORATORIES
11.7 WATERS CORPORATION
11.8 HUMAN METABOLOME TECHNOLOGIES
11.9 NEXTGEN METABOLOMICS
11.10 BIOCRATES LIFE SCIENCES AG
11.11 STEMINA BIOMARKER
11.12 PHENOMENOME
11.13 METANOMICS GMBH
11.14 ACCELRYS
11.15 EISAI CO. LTD.
11.16 SHIMADZU CORPORATION
11.17 SIDMAP, LLC
11.18 ASTRAZENECA PLC
11.19 AB SCIEX
11.20 METABOLOMX
11.21 RESEARCH INSTITUTE OF CHROMATOGRAPHY (RIC)

12 APPENDIX

12.1 Key Patents

13 GLOSSARY 133-134

LIST OF TABLES

1 Global Metabolomics Market Revenue, by Regional ($Million)
2 Global Metabolomics Market Revenue, by Indication ($Million)
3 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Oncology Indication
4 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Cardiology Indication
5 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Neurology Indication
6 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Indications
7 Global Metabolomics Market Revenue, By Application ($Million)
8 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Bio Marker Discovery Application
9 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Drug Discovery Application
10 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Toxicology Testing Application
11 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Applications

LIST OF OTHER TABLES

1 Market Dynamics-Drivers Impact By Timeline
2 Market Dynamics-Restraints Impact By Timeline
3 Opportunity Strategic Evaluation Analysis
4 Mergers And Acquisitions
5 New Product Developments
6 Collaborations
7 Key Patents 131-132

LIST OF FIGURES

FIG 1 Research Methodology
FIG 2 Global Metabolomics Market Revenue, 2012 – 2017 ($Million)
FIG 3 Market Share By Region, 2012 – 2017 (%)
FIG 4 Key Application Areas
FIG 5 Flow chart of Nutri-Genomics
FIG 6 Conceptual Approach
FIG 7 Value Chain Analysis
FIG 8 Percentage of stake holders in metabolomics value chain
FIG 9 Global Metabolomics Market Segmentation
FIG 10 Global Metabolomics Market Revenue Forecast, 2012 - 2017 ($Million)
FIG 11 Global Metabolomics Market Revenue, by Regional ($Million)
FIG 12 Global Metabolomics Market Y-O-Y Growth Rate, By Region
FIG 13 Market Share, By Region, 2012 – 2017 (%)
FIG 14 Global Metabolomics Market Revenue, by Indication ($Million)
FIG 15 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Oncology Indication
FIG 16 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Cardiology Indication
FIG 17 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Neurology Indication
FIG 18 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Indications
FIG 19 Global Market Share, By Indication, 2012 – 2017 (%)
FIG 20 Global Metabolomics Market Revenue, By Application ($Million)
FIG 21 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Bio Marker Discovery Application
FIG 22 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Drug Discovery Application
FIG 23 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Toxicology Testing Application
FIG 24 Global Metabolomics Market Revenue ($Million), Y-O-Y Growth (%), By Other Applications
FIG 25 Global Percentage Distribution of Metabolomics Market, By Applications, 2012 – 2017 (%)
FIG 26 Demand Side Analysis
FIG 27 Investment Client Networks
FIG 28 Opportunity Strategic Evaluation Analysis
FIG 29 Regions with High Technology Adoption
FIG 30 Patent Distribution Among Top Players
FIG 31 AHP Analysis
FIG 32 Priority Values
FIG 33 Comparison of Devices Based on Level 0 Criteria
FIG 34 Technology Prioritization and AHP Analysis Findings
FIG 35 Technology Roadmap
FIG 36 Strategic Recommendations for Technology & Business Management

Ask Your Question

Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: